Deep Track Capital »

Altimmune shares owned by Deep Track Capital

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $59M 19M 3.04

More positions owned by Deep Track Capital

Guardant Health (GH)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Vaxcyte (PCVX)
Alnylam Pharmaceuticals (ALNY)
Veradermics Common Stock (MANE)
Genmab A/s Sponsored Ads (GMAB)
Tarsus Pharmaceuticals (TARS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Ocular Therapeutix (OCUL)
BioMarin Pharmaceutical (BMRN)
Nurix Therapeutics (NRIX)
Oruka Therapeutics (ORKA)
Alumis (ALMS)

View all positions for Deep Track Capital

Top funds holding Altimmune

BlackRock
Deep Track Capital
TCG Crossover Management
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Marshall Wace
Viking Global Investors
RA Capital Management
Geode Capital Management
Woodline Partners
Millennium Management
Susquehanna International
Trails Edge Capital Partners
Nuveen

View all funds holding Altimmune